Ms. Nicole Lemerond - 08 Aug 2022 Form 3 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role: Director
Signature: /s/ Eric Adams, attorney-in-fact for Ms. Nicole Lemerond
Issuer symbol: INM
Transactions as of: 08 Aug 2022
Net transactions value: $0
Form type: 3
Filing time: 10 Aug 2022, 20:14:01 UTC
Next filing: 10 Aug 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney